Biology of renal cancer tumor thrombus - towards the personalized approach

IF 5.5 2区 医学 Q1 HEMATOLOGY
Sumit Sharma , Michał Kunc , Mieszko Czapliński , Weronika Łyzińska , Rafał Pęksa , Le Qu , Piotr Radziszewski , Łukasz Zapała
{"title":"Biology of renal cancer tumor thrombus - towards the personalized approach","authors":"Sumit Sharma ,&nbsp;Michał Kunc ,&nbsp;Mieszko Czapliński ,&nbsp;Weronika Łyzińska ,&nbsp;Rafał Pęksa ,&nbsp;Le Qu ,&nbsp;Piotr Radziszewski ,&nbsp;Łukasz Zapała","doi":"10.1016/j.critrevonc.2025.104731","DOIUrl":null,"url":null,"abstract":"<div><div>Renal cell carcinoma - related thrombus arising within venous system (venous tumor thrombus, VTT) represents a distinct compartment within cancer, situated at the frontline with the continual interaction with host blood cells. Various host immune blood cells may possibly interact with VTT influencing its biology. While many authors have reviewed the current state-of-the-art of the management of VTT, its biology and microenvironment has not been comprehensively reviewed to date. In this narrative review, we described the current concepts on formation of thrombus, its histopathology, immune microenvironment, genetic and molecular features with potential impact on prognostication and tailored therapy. Although it is the sophisticated and challenging surgery that remains the primary modality in the management of RCC with VTT, recent advances in the research on cancer biology and microenvironment shed some light on the numerous future perspectives. The formation of tumor thrombus is a complex process, understanding of which may trigger onset of novel therapies leading to the improvement of not only oncological results but also patients’ safety in these life-threatening conditions.</div></div>","PeriodicalId":11358,"journal":{"name":"Critical reviews in oncology/hematology","volume":"211 ","pages":"Article 104731"},"PeriodicalIF":5.5000,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical reviews in oncology/hematology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1040842825001192","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Renal cell carcinoma - related thrombus arising within venous system (venous tumor thrombus, VTT) represents a distinct compartment within cancer, situated at the frontline with the continual interaction with host blood cells. Various host immune blood cells may possibly interact with VTT influencing its biology. While many authors have reviewed the current state-of-the-art of the management of VTT, its biology and microenvironment has not been comprehensively reviewed to date. In this narrative review, we described the current concepts on formation of thrombus, its histopathology, immune microenvironment, genetic and molecular features with potential impact on prognostication and tailored therapy. Although it is the sophisticated and challenging surgery that remains the primary modality in the management of RCC with VTT, recent advances in the research on cancer biology and microenvironment shed some light on the numerous future perspectives. The formation of tumor thrombus is a complex process, understanding of which may trigger onset of novel therapies leading to the improvement of not only oncological results but also patients’ safety in these life-threatening conditions.
肾癌肿瘤血栓的生物学研究——走向个体化
静脉系统内产生的肾癌相关血栓(静脉肿瘤血栓,VTT)代表了癌症中一个独特的隔室,位于与宿主血细胞持续相互作用的前线。多种宿主免疫血细胞可能与VTT相互作用,影响其生物学特性。虽然许多作者已经回顾了目前VTT管理的最新技术,但其生物学和微环境尚未得到全面的审查。在这篇叙述性的综述中,我们描述了目前血栓形成的概念,其组织病理学,免疫微环境,遗传和分子特征,以及对预后和量身定制治疗的潜在影响。尽管复杂且具有挑战性的手术仍然是治疗RCC VTT的主要方式,但癌症生物学和微环境研究的最新进展揭示了许多未来的前景。肿瘤血栓的形成是一个复杂的过程,了解这一过程可能会引发新疗法的出现,不仅会改善肿瘤结果,还会提高患者在这些危及生命的疾病中的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.00
自引率
3.20%
发文量
213
审稿时长
55 days
期刊介绍: Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信